| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/GUT.2008.157297 |
| P698 | PubMed publication ID | 18719139 |
| P2093 | author name string | M Parkes | |
| F Bredin | |||
| D C O Massey | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sirolimus | Q32089 |
| P304 | page(s) | 1294-1296 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Use of sirolimus (rapamycin) to treat refractory Crohn's disease | |
| P478 | volume | 57 |
| Q28082887 | ATG16L1: A multifunctional susceptibility factor in Crohn disease |
| Q42221088 | Altered autophagy induction by sera from pregnant women with pre-eclampsia: a case-control study |
| Q42408122 | Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response? |
| Q38074783 | Autophagy and Crohn's disease. |
| Q37764367 | Autophagy and Crohn's disease: at the crossroads of infection, inflammation, immunity, and cancer |
| Q38074032 | Autophagy and inflammatory diseases |
| Q36116965 | Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease |
| Q38099513 | Autophagy: a new target or an old strategy for the treatment of Crohn's disease? |
| Q37472903 | Autophagy: from basic science to clinical application |
| Q64243021 | Autophagy: roles in intestinal mucosal homeostasis and inflammation |
| Q34024046 | Barrier- and autophagic functions of the intestinal epithelia: role of disturbances in the pathogenesis of Crohn’s disease |
| Q40139185 | Basiliximab treatment for autoimmune bowel disease in a pediatric heart transplant patient |
| Q50065054 | Biopsy-derived Intestinal Epithelial Cell Cultures for Pathway-based Stratification of Patients With Inflammatory Bowel Disease. |
| Q58692935 | Boosting mTOR-dependent autophagy via upstream TLR4-MyD88-MAPK signalling and downstream NF-κB pathway quenches intestinal inflammation and oxidative stress injury |
| Q42252132 | Cellular and molecular mechanisms of intestinal fibrosis |
| Q28243129 | Comparison between procaine and isocarboxazid metabolism in vitro by a liver microsomal amidase-esterase |
| Q92409140 | Crohn's Disease: Potential Drugs for Modulation of Autophagy |
| Q34025428 | Crohn's disease: NOD2, autophagy and ER stress converge |
| Q41867220 | D'oh! genes and environment cause Crohn's disease |
| Q42223966 | Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity? |
| Q35633085 | Digesting the genetics of inflammatory bowel disease: insights from studies of autophagy risk genes |
| Q38286034 | Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future |
| Q49965391 | Epithelial-mesenchymal transition in Crohn's disease |
| Q34288268 | Etiology of Crohn's disease: many roads lead to autophagy |
| Q83613913 | Genes in inflammatory bowel disease: lessons from complex diseases |
| Q37857566 | Genome-wide association studies and Crohn's disease |
| Q50317203 | Genome-wide association studies in Crohn's disease: Past, present and future. |
| Q38756562 | Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications |
| Q34631825 | How tolerogenic dendritic cells induce regulatory T cells |
| Q33761278 | Immunoregulatory functions of mTOR inhibition. |
| Q37733598 | Impact on Autophagy and Ultraviolet B Induced Responses of Treatment with the MTOR Inhibitors Rapamycin, Everolimus, Torin 1, and pp242 in Human Keratinocytes |
| Q41646324 | Induction of the 70 kDa heat shock protein stress response inhibits autophagy: possible consequences for pregnancy outcome |
| Q28066443 | Inflammatory Bowel Disease Drugs: A Focus on Autophagy |
| Q37989394 | Inflammatory bone loss: pathogenesis and therapeutic intervention |
| Q45344347 | Inhibition of autophagy by sera from pregnant women |
| Q37570542 | Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease |
| Q37735484 | Links of Autophagy Dysfunction to Inflammatory Bowel Disease Onset |
| Q41879637 | Localization of ανβ6 integrin-TGF-β1/Smad3, mTOR and PPARγ in experimental colorectal fibrosis |
| Q34802103 | Mammalian target of rapamycin complex 1 activation is required for the stimulation of human skeletal muscle protein synthesis by essential amino acids |
| Q38293779 | Mechanisms of initiation and progression of intestinal fibrosis in IBD. |
| Q34504710 | Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review |
| Q37399077 | Morbus Crohn--a disease of failing macroautophagy in the immune system? |
| Q91733501 | New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD |
| Q38008987 | Nutrient modulation of autophagy: implications for inflammatory bowel diseases |
| Q64103975 | One Size Does Not Fit All: The Case for Translational Medicine |
| Q35659341 | Pathogenesis of Crohn's disease |
| Q91430002 | Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation |
| Q90156769 | Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases? |
| Q55049043 | Sirolimus in Refractory Cronkhite-Canada Syndrome and Focus on Standard Treatment. |
| Q36347242 | TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium. |
| Q52723241 | The colonic epithelium plays an active role in promoting colitis by shaping the tissue cytokine profile. |
| Q42115878 | The study of gastric mucosa for possible bacterial causative agent of Crohn's disease |
| Q38618178 | Therapeutic innovations in inflammatory bowel diseases |
| Q36759434 | Tissue-resident dendritic cells and diseases involving dendritic cell malfunction |
| Q38026408 | Towards a novel molecular classification of IBD. |
| Q35947162 | Towards an integrated understanding of the therapeutic utility of exclusive enteral nutrition in the treatment of Crohn's disease |
| Q38229078 | mTOR signaling in T cell immunity and autoimmunity |
| Q92703579 | mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease |
Search more.